Sign In

Login

Password

Forgot Password ? Sign Up

Guz chromochłonny (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Guz chromochłonny" in Polish language version.

refsWebsite
Global rank Polish rank
48nih.gov
4th place
7th place
11doi.org
2nd place
6th place

doi.org

  • Madani R., Al-Hashmi M., Bliss R., Lennard T.W. Ectopic pheochromocytoma: does the rule of tens apply?. „World journal of surgery”. 4 (31), s. 849–854, 2007. DOI: 10.1007/s00268-006-0608-1. PMID: 17372668. 
  • Adjallé R., Plouin P.F., Pacak K., Lehnert H. Treatment of Malignant Pheochromocytoma. „Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme”, 2009. DOI: 10.1055/s-0029-1231025. PMID: 19672813. 
  • Kopetschke R., Slisko M., Kilisli A., Tuschy U., Wallaschofski H., Fassnacht M., Ventz M., Beuschlein F., Reincke M., Reisch N., Quinkler M. Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. „European journal of endocrinology / European Federation of Endocrine Societies”. 2 (161), s. 355–361, 2009. DOI: 10.1530/EJE-09-0384. PMID: 19497985. 
  • Beal M.F., Atuk N.O., Westfall T.C., Turner S.M. Catecholamine uptake, accumulation, and release in acute porphyria. „The Journal of clinical investigation”. 5 (60), s. 1141–1148, 1977. DOI: 10.1172/JCI108866. PMID: 908757. 
  • Sibal L., Jovanovic A., Agarwal S.C., Peaston R.T., James R.A., Lennard T.W., Bliss R., Batchelor A., Perros P. Phaeochromocytomas presenting as acute crises after beta blockade therapy. „Clinical endocrinology”. 2 (65), s. 186–190, 2006. DOI: 10.1111/j.1365-2265.2006.02571.x. PMID: 16886958. 
  • Tiberio G.A., Baiocchi G.L., Arru L., Agabiti Rosei C., De Ponti S., Matheis A., Rizzoni D., Giulini S.M. Prospective randomized comparison of laparoscopic vesrsus open adrenalectomy for sporadic pheochromocytoma. „Surgical endoscopy”. 6 (22), s. 1435–1439, 2008. DOI: 10.1007/s00464-008-9904-1. PMID: 18398641. 
  • Safford S.D., Coleman R.E., Gockerman J.P., Moore J., Feldman J.M., Leight G.S., Tyler D.S., Olson J.A. Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma. „Surgery”. 6 (134), s. 956–962; discussion 962–3, 2003. DOI: 10.1016/S0039. PMID: 14668728. 
  • Rose B., Matthay K.K., Price D., Huberty J., Klencke B., Norton J.A., Fitzgerald P.A. High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma. „Cancer”. 2 (98), s. 239–248, 2003. DOI: 10.1002/cncr.11518. PMID: 12872341. 
  • Maloney A., Workman P. HSP90 as a new therapeutic target for cancer therapy: the story unfolds. „Expert opinion on biological therapy”. 1 (2), s. 3–24, 2002. DOI: 10.1517/14712598.2.1.3. PMID: 11772336. 
  • Khorram-Manesh A., Jansson S., Wängberg B., Nilsson O., Tisell L.E., Ahlman H. Mortality associated with pheochromocytoma: increased risk for additional tumors. „Annals of the New York Academy of Sciences”, s. 444–448, 2006. DOI: 10.1196/annals.1353.048. PMID: 17102113. 
  • Khorram-Manesh A., Ahlman H., Nilsson O., Odén A., Jansson S. Mortality associated with pheochromocytoma in a large Swedish cohort. „European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology”. 5 (30), s. 556–559, 2004. DOI: 10.1016/j.ejso.2004.03.006. PMID: 15135486. 

nih.gov

ncbi.nlm.nih.gov

  • Madani R., Al-Hashmi M., Bliss R., Lennard T.W. Ectopic pheochromocytoma: does the rule of tens apply?. „World journal of surgery”. 4 (31), s. 849–854, 2007. DOI: 10.1007/s00268-006-0608-1. PMID: 17372668. 
  • Adjallé R., Plouin P.F., Pacak K., Lehnert H. Treatment of Malignant Pheochromocytoma. „Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme”, 2009. DOI: 10.1055/s-0029-1231025. PMID: 19672813. 
  • Kopetschke R., Slisko M., Kilisli A., Tuschy U., Wallaschofski H., Fassnacht M., Ventz M., Beuschlein F., Reincke M., Reisch N., Quinkler M. Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. „European journal of endocrinology / European Federation of Endocrine Societies”. 2 (161), s. 355–361, 2009. DOI: 10.1530/EJE-09-0384. PMID: 19497985. 
  • Maher E.R, Eng C. The pressure rises: update on the genetics of phaeochromocytoma. „Human molecular genetics”. 20 (11), s. 2347–2354, 2002. PMID: 12351569. 
  • D.E. Gennes L., Bricaire H., Moreau L., Courjaret J., Blanc G., Pasquier P. [Pheochromocytoma with true orthostatic hypotension. Report of a case and review of the literature]. „Bulletins et mémoires de la Société médicale des hôpitaux de Paris”, s. 1035–1048, 1963. PMID: 14098864. 
  • Martín Osés E., Páez Borda A., Luján Galán M., Ruiz de la Roja J.C., Sánchez Sánchez E., Berenguer Sánchez A. [Bladder pheochromocytoma: a rare cause of ureterohydronephrosis]. „Archivos españoles de urología”. 8 (50), s. 915–917, 1997. PMID: 9463292. 
  • Gluvić Z., Rasić-Milutinović Z. [Pheochromocytoma associated with cholelithiasis]. „Medicinski pregled”. 7–8 (54). s. 383–386. PMID: 11905191. 
  • Tsai J.J., Tsai W.J., Yen J.H., Chen J.R., Lin S.F., Liu H.W. Malignant pheochromocytoma associated with Jaccoud’s-type arthropathy, Raynaud’s phenomenon, positive antinuclear antibody and rheumatoid factor. „Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences”. 9 (10), s. 518–521, 1994. PMID: 7983696. 
  • Suzuki K., Miyashita A., Inoue Y., Iki S., Enomoto H., Takahashi Y., Takemura T. Interleukin-6-producing pheochromocytoma. „Acta haematologica”. 4 (85), s. 217–219, 1991. PMID: 1853686. 
  • Little R.A., Frayn K.N., Randall P.E., Stoner H.B., Morton C., Yates D.W., Laing G.S. Plasma catecholamines in the acute phase of the response to myocardial infarction. „Archives of emergency medicine”. 1 (3), s. 20–27, 1986. PMID: 3524599. 
  • Ahmad J., Kham A.S., Siddiqui M.A. Estimation of plasma and urinary catecholamines in Guillain-Barré syndrome. „Japanese journal of medicine”. 1 (24), s. 24–29, 1985. PMID: 3999461. 
  • Beal M.F., Atuk N.O., Westfall T.C., Turner S.M. Catecholamine uptake, accumulation, and release in acute porphyria. „The Journal of clinical investigation”. 5 (60), s. 1141–1148, 1977. DOI: 10.1172/JCI108866. PMID: 908757. 
  • Blum I., Weinstein R., Sztern M., Lahav M. Adrenergic receptor hyperactivity--a cause for pseudopheochromocytoma?. „Medical hypotheses”. 1 (22), s. 89–96, 1987. PMID: 3031435. 
  • van der Horst-Schrivers A.N., Kerstens M.N., Wolffenbuttel B.H. Preoperative pharmacological management of phaeochromocytoma. „The Netherlands journal of medicine”. 8 (64), s. 290–295, 2006. PMID: 16990692. 
  • Sloand E.M., Thompson B.T. Propranolol-induced pulmonary edema and shock in a patient with pheochromocytoma. „Archives of internal medicine”. 1 (144), s. 173–174, 1984. PMID: 6691755. 
  • Sibal L., Jovanovic A., Agarwal S.C., Peaston R.T., James R.A., Lennard T.W., Bliss R., Batchelor A., Perros P. Phaeochromocytomas presenting as acute crises after beta blockade therapy. „Clinical endocrinology”. 2 (65), s. 186–190, 2006. DOI: 10.1111/j.1365-2265.2006.02571.x. PMID: 16886958. 
  • Kanto J.H. Current status of labetalol, the first alpha- and beta-blocking agent. „International journal of clinical pharmacology, therapy, and toxicology”. 11 (23), s. 617–628, 1985. PMID: 2867049. 
  • Feek C.M., Earnshaw P.M. Hypertensive response to labetalol in phaeochromocytoma. „British medical journal”. 6236 (281), s. 387, 1980. PMID: 7427286. 
  • Ulchaker J.C., Goldfarb D.A., Bravo E.L., Novick A.C. Successful outcomes in pheochromocytoma surgery in the modern era. „The Journal of urology”. 3 (161), s. 764–767, 1999. PMID: 10022680. 
  • Tiberio G.A., Baiocchi G.L., Arru L., Agabiti Rosei C., De Ponti S., Matheis A., Rizzoni D., Giulini S.M. Prospective randomized comparison of laparoscopic vesrsus open adrenalectomy for sporadic pheochromocytoma. „Surgical endoscopy”. 6 (22), s. 1435–1439, 2008. DOI: 10.1007/s00464-008-9904-1. PMID: 18398641. 
  • Jaroszewski D.E., Tessier D.J., Schlinkert R.T., Grant C.S., Thompson G.B., van Heerden J.A., Farley D.R., Smith S.L., Hinder R.A. Laparoscopic adrenalectomy for pheochromocytoma. „Mayo Clinic proceedings. Mayo Clinic”. 12 (78), s. 1501–1504, 2003. PMID: 14661679. 
  • John H., Ziegler W.H., Hauri D., Jaeger P. Pheochromocytomas: can malignant potential be predicted?. „Urology”. 4 (53), s. 679–683, 1999. PMID: 10197840. 
  • Mishra A.K., Agarwal G., Kapoor A., Agarwal A., Bhatia E., Mishra S.K. Catecholamine cardiomyopathy in bilateral malignant pheochromocytoma: successful reversal after surgery. „International journal of cardiology”. 1 (76), s. 89–90, 2000. PMID: 11121600. 
  • Takahashi K., Ashizawa N., Minami T., Suzuki S., Sakamoto I., Hayashi K., Tomiyasu S., Sumikawa K., Kitamura K., Eto T., Yano K. Malignant pheochromocytoma with multiple hepatic metastases treated by chemotherapy and transcatheter arterial embolization. „Internal medicine (Tokyo, Japan)”. 4 (38), s. 349–354, 1999. PMID: 10361908. 
  • Pacak K., Fojo T., Goldstein D.S., Eisenhofer G., Walther M.M., Linehan W.M., Bachenheimer L., Abraham J., Wood B.J. Radiofrequency ablation: a novel approach for treatment of metastatic pheochromocytoma. „Journal of the National Cancer Institute”. 8 (93), s. 648–649, 2001. PMID: 11309443. 
  • Averbuch S.D., Steakley C.S., Young R.C., Gelmann E.P., Goldstein D.S., Stull R., Keiser H.R. Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. „Annals of internal medicine”. 4 (109), s. 267–273, 1988. PMID: 3395037. 
  • Safford S.D., Coleman R.E., Gockerman J.P., Moore J., Feldman J.M., Leight G.S., Tyler D.S., Olson J.A. Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma. „Surgery”. 6 (134), s. 956–962; discussion 962–3, 2003. DOI: 10.1016/S0039. PMID: 14668728. 
  • Rose B., Matthay K.K., Price D., Huberty J., Klencke B., Norton J.A., Fitzgerald P.A. High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma. „Cancer”. 2 (98), s. 239–248, 2003. DOI: 10.1002/cncr.11518. PMID: 12872341. 
  • Loh K.C., Fitzgerald P.A., Matthay K.K., Yeo P.P., Price D.C. The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients. „Journal of endocrinological investigation”. 11 (20), s. 648–658, 1997. PMID: 9492103. 
  • Decoulx M., Wemeau J.L., Racadot-Leroy N., Grimbert I., Proye C., Plane C. [Alpha-methyl-paratyrosine in the treatment of malignant pheochromocytoma]. „La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne”. 4 (8). s. 383–388. PMID: 3423477. 
  • Lehnert H., Mundschenk J., Hahn K. Malignant pheochromocytoma. „Frontiers of hormone research”, s. 155–162, 2004. PMID: 14674310. 
  • Wiseman G.A., Kvols L.K. Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues. „Seminars in nuclear medicine”. 3 (25), s. 272–278, 1995. PMID: 7570046. 
  • Invitti C., De Martin I., Bolla G.B., Pecori Giraldi F., Maestri E., Leonetti G., Cavagnini F. Effect of octreotide on catecholamine plasma levels in patients with chromaffin cell tumors. „Hormone research”. 4 (40), s. 156–160, 1993. PMID: 8300064. 
  • Lamarre-Cliche M., Gimenez-Roqueplo A.P., Billaud E., Baudin E., Luton J.P., Plouin P.F. Effects of slow-release octreotide on urinary metanephrine excretion and plasma chromogranin A and catecholamine levels in patients with malignant or recurrent phaeochromocytoma. „Clinical endocrinology”. 5 (57), s. 629–634, 2002. PMID: 12390337. 
  • Boltze C., Mundschenk J., Unger N., Schneider-Stock R., Peters B., Mawrin C., Hoang-Vu C., Roessner A., Lehnert H. Expression profile of the telomeric complex discriminates between benign and malignant pheochromocytoma. „The Journal of clinical endocrinology and metabolism”. 9 (88), s. 4280–4286, 2003. PMID: 12970299. 
  • Maloney A., Workman P. HSP90 as a new therapeutic target for cancer therapy: the story unfolds. „Expert opinion on biological therapy”. 1 (2), s. 3–24, 2002. DOI: 10.1517/14712598.2.1.3. PMID: 11772336. 
  • Khorram-Manesh A., Jansson S., Wängberg B., Nilsson O., Tisell L.E., Ahlman H. Mortality associated with pheochromocytoma: increased risk for additional tumors. „Annals of the New York Academy of Sciences”, s. 444–448, 2006. DOI: 10.1196/annals.1353.048. PMID: 17102113. 
  • Khorram-Manesh A., Ahlman H., Nilsson O., Odén A., Jansson S. Mortality associated with pheochromocytoma in a large Swedish cohort. „European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology”. 5 (30), s. 556–559, 2004. DOI: 10.1016/j.ejso.2004.03.006. PMID: 15135486. 
  • Pruszczyk P., Januszewicz W., Feltynowski T., Chodakowska J., Wocial B., Pachocki R., Nielubowicz J., Szostek M. Long term follow-up after surgical removal of pheochromocytoma--observations in 61 patients. „Clinical and experimental hypertension. Part A, Theory and practice”. 6–7 (13), s. 1179–1194, 1991. PMID: 1760886. 
  • Fränkel F. Classics in oncology. A case of bilateral completely latent adrenal tumor and concurrent nephritis with changes in the circulatory system and retinitis: Felix Fränkel, 1886. „CA: a cancer journal for clinicians”. 2 (34). s. 93–106. PMID: 6423225. 
  • Welbourn R.B. Early surgical history of phaeochromocytoma. „The British journal of surgery”. 7 (74), s. 594–596, 1987. PMID: 3304519. 
  • Engel A., von Euler U.S. Diagnostic value of increased urinary output of pheochromocytoma. „Lancet”. 6630 (2), s. 387, 1950. PMID: 14785169. 
  • WEIL-MALHERBE H. Phaeochromocytoma catechols in urine and tumour tissue. „Lancet”. 6937 (271), s. 282–284, 1956. PMID: 13347128. 
  • Armstrong M.D., McMillan A., Shaw K.N. 3-Methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrine. „Biochimica et biophysica acta”. 2 (25), s. 422–423, 1957. PMID: 13471587. 
  • Lawrence A.M. Glucagon provocative test for pheochromocytoma. „Annals of internal medicine”. 6 (66), s. 1091–1096, 1967. PMID: 6027944. 
  • Stewart B.H., Bravo E.L., Haaga J., Meaney T.F., Tarazi R. Localization of pheochromocytoma by computed tomography. „The New England journal of medicine”. 9 (299), s. 460–461, 1978. PMID: 683279. 
  • Sisson J.C., Frager M.S., Valk T.W., Gross M.D., Swanson D.P., Wieland D.M., Tobes M.C., Beierwaltes W.H., Thompson N.W. Scintigraphic localization of pheochromocytoma. „The New England journal of medicine”. 1 (305), s. 12–17, 1981. PMID: 7231514. 
  • Neumann H.P., Berger D.P., Sigmund G., Blum U., Schmidt D., Parmer R.J., Volk B., Kirste G. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. „The New England journal of medicine”. 21 (329), s. 1531–1538, 1993. PMID: 8105382.